RUSH (evaluating the efficacy of rosuvastatin for Korean dyslipidemia patients with hypertension in real world practice).

Trial Profile

RUSH (evaluating the efficacy of rosuvastatin for Korean dyslipidemia patients with hypertension in real world practice).

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Nov 2010

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms RUSH
  • Sponsors AstraZeneca
  • Most Recent Events

    • 14 Oct 2008 Planned end date changed to 1 Nov 2007 as reported by ClinicalTrials.gov.
    • 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top